Global Dyspepsia Drugs Market Size To Worth Exceed USD 14.7 Billion By 2033 | CAGR Of 4.46%
May 30, 2024 21:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , May 30, 2024 (GLOBE NEWSWIRE) -- The Global Dyspepsia Drugs Market Size is to Grow from USD 9.5 Billion in 2023 to USD 14.7 Billion by 2033, at a Compound Annual Growth...
Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affairs
May 30, 2024 16:05 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced the appointment of Robert M. Cuddihy, M.D., as senior vice president of Medical Affairs....
OSE Immunotherapeutics fait le point sur ses avancées et sur la stratégie de croissance de la Société
May 30, 2024 12:15 ET
|
OSE Immunotherapeutics
OSE Immunotherapeutics fait le point sur ses avancées et sur la stratégie de croissance de la Société Trois accords pharmaceutiques signés au cours des trois derniers mois : Un nouveau partenariat...
OSE Immunotherapeutics Provides Business and Corporate Update
May 30, 2024 12:15 ET
|
OSE Immunotherapeutics
OSE Immunotherapeutics Provides Business and Corporate Update Three pharmaceutical agreements signed during the last three months: New strategic partnership with AbbVie for OSE-230, a novel...
Communiqué de presse : Sanofi finalise l’acquisition d’Inhibrx, Inc.
May 30, 2024 09:01 ET
|
Sanofi - Aventis Groupe
Sanofi finalise l’acquisition d’Inhibrx, Inc. Paris, le 30 mai 2024. Sanofi annonce aujourd’hui la finalisation de son acquisition d’Inhibrx, Inc. (« Inhibrx »). Cette opération ajoute le SAR447537...
Press Release: Sanofi completes acquisition of Inhibrx, Inc.
May 30, 2024 09:01 ET
|
Sanofi - Aventis Groupe
Sanofi completes acquisition of Inhibrx, Inc. Paris, May 30, 2024. Sanofi announced today the completion of its acquisition of Inhibrx, Inc. (“Inhibrx”). The acquisition adds SAR447537 (formerly...
SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company’s growth
May 30, 2024 07:00 ET
|
BTG Specialty Pharmaceuticals
Philadelphia, PA, May 30, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, has appointed Vanessa Wolfeler as its new Chief Executive Officer (CEO) effective...
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
May 29, 2024 07:00 ET
|
Omega Therapeutics
CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable...
IGM Biosciences to Present at the Jefferies Healthcare Conference
May 29, 2024 07:00 ET
|
IGM Biosciences, Inc.
MOUNTAIN VIEW, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today...
Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors
May 28, 2024 16:01 ET
|
Keros Therapeutics, Inc.
LEXINGTON, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and...